Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human therapeutics based on triple helix technology.

J M Chubb1, M E Hogan

  • 1Triplex Pharmaceutical Corporation, The Woodlands, TX 77380.

Trends in Biotechnology
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allelopathy of small everlasting (Antennaria microphylla) : Phytotoxicity to leafy spurge (Euphorbia esula) in tissue culture.

Journal of chemical ecology·2013
Same author

Differential allelochemical detoxification mechanism in tissue cultures ofAntennaria microphylla andEuphorbia esula.

Journal of chemical ecology·2013
Same author

Effect of temperature and sucrose concentration on hydroquinone toxicity in leafy spurge suspension culture cells.

Journal of chemical ecology·2013
Same author

Varieties of positive and negative priming.

Psychonomic bulletin & review·2013
Same author

Impairment in the achievement domain in bipolar spectrum disorders: role of behavioral approach system hypersensitivity and impulsivity.

Minerva pediatrica·2008
Same author

Childhood maltreatment and college students' current suicidal ideation: a test of the hopelessness theory.

Suicide & life-threatening behavior·2002
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
See all related articles

Triple helix technology is enabling new drugs for viral infections, with potential for cancer and immune disorders. Research is addressing drug stability, delivery, and efficacy, showing promising early results.

Area of Science:

  • Biotechnology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Triple helix technology represents a novel approach in rational drug discovery.
  • This technology is paving the way for a new class of therapeutic agents.

Purpose of the Study:

  • To explore the application of triple helix technology in developing drugs for viral infections.
  • To investigate the potential of these drugs for treating cancer and immunological disorders.
  • To address key challenges in the development of triple helix-based therapeutics.

Main Methods:

  • Focus on addressing critical issues including stability, delivery, specificity, in vitro efficacy, and acute toxicity.
  • Preliminary studies are being conducted to evaluate these parameters.
  • Chemical modifications of oligonucleotides are being explored to enhance drug properties.

Related Experiment Videos

Main Results:

  • Preliminary studies have yielded promising results regarding the efficacy and safety of triple helix-based compounds.
  • Initial investigations indicate the potential for effective and specific treatment of viral infections.

Conclusions:

  • Triple helix technology holds significant promise for developing novel therapeutics.
  • Further research is required, including comprehensive pharmacokinetic and in vivo efficacy studies, to fully realize the potential of these drugs.
  • Ongoing R&D efforts are focused on scale-up synthesis and pharmaceutical formulation.